Yes, they will start from castration resistant prostate cancer patients
Niclosamide-based metabolic anticance... - Advanced Prostate...
Niclosamide-based metabolic anticancer drug's first clinical trial will target CRPC
![Maxone73 profile image](https://images.hu-production.be/avatars/cc6cfcd066d747309f3dc14136bd6475_small@2x_100x100.jpg)
Written by
![Maxone73 profile image](https://images.hu-production.be/avatars/cc6cfcd066d747309f3dc14136bd6475_small@2x_100x100.jpg)
Maxone73
To view profiles and participate in discussions please or .
Read more about...
1 Reply
•
Not what you're looking for?
You may also like...
Phase 1-2 study for niclosamide-based drug:
or-niclosamide-based-drug/
New Drug BAY1841788 (ODM-201) has been successful for CRPC patients, Clinical trial Phase III completed.
This drug is for patients with Castration Resistance Prostate Cancer , apparently the clinical trial
Dr Slovin from MSKCC discusses treatments for advanced prostate cancer
approaches to Castration Resistant Prostate Cancer, for patients who need to know...
PSMA-targeted radiopharmaceutical clinical trials in the US
Now that the VISION trial of Lu-177-PSMA-617 is no longer recruiting, some patients are wondering...
Repurposing off label drugs for cancer/targeting metabolic pathways. Is anyone participating in this trial?
There is a trial underway at the Care Clinic in Harley Street that are seemingly trialing a similar...